1-4 of 4
Hülya Bilgen
Close
Sort by
Journal Articles

Comparison of Efficacy and Safety of Generic Plerixafor Vs Original Plerixafor in the Mobilization of Myeloma Patients

Omur Sevindik, Hülya Bilgen, Istemi Serin, Elif Melek, Volkan Karakuş, Kübra Çerçi, Yaşa Gül Mutlu, Berrin Balik Aydin, Sevil Sadri, Hüseyin Beköz, Leylagül Kaynar
Journal: Blood
Blood (2022) 140 (Supplement 1): 12803–12804.
https://doi.org/10.1182/blood-2022-168558
Published: 2022
Journal Articles

Autologous Stem Cell Collection In Lymphoma and Myeloma Patients: Single Center Analysis With Intention To Successful Mobilization and Collection Under Restricted Permission For Use Of Plerixafor

Baris Hasbal, MD, Hulya Bilgen, MD, Tulay Ozcelik, MD, Fehmi Hindilerden, MD, Serkan Guvenc, MD, Songul Serefhanoglu, MD, Reyhan Küçükkaya, MD, Mutlu Arat, MD
Journal: Blood
Blood (2013) 122 (21): 5443.
https://doi.org/10.1182/blood.V122.21.5443.5443
Published: 2013
Journal Articles

Cytokine Gene Polymorphisms in Turkish Patients with Childhood Chronic Myeloid Leukemia.

Kursat Ozdilli, MD, PhD, Fatma Oguz, MD, PhD., Yeliz Duvarci, Hulya Bilgen, MD, PhD., Sema Anak, MD, Mahmut Carin, PhD., Gunduz Gedikoglu, MD
Journal: Blood
Blood (2005) 106 (11): 4368.
https://doi.org/10.1182/blood.V106.11.4368.4368
Published: 2005
Journal Articles

Cytokine Gene Polymorphisms in Turkish Patients with Childhood Acute Lymphoblastic Leukemia.

Kursat Ozdilli, MD, Phd., Fatma Oguz, MD., Phd., Hulya Bilgen, MD., Phd., Yeliz Duvarci, MSc., Halim Issever, Phd., Sema Anak, MD., Mahmut Carin, PhD., Gunduz Gedikoglu, MD.
Journal: Blood
Blood (2004) 104 (11): 4441.
https://doi.org/10.1182/blood.V104.11.4441.4441
Published: 2004